| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |